SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-24-006156
Filing Date
2024-02-22
Accepted
2024-02-22 07:42:52
Documents
77
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K itci-20231231.htm   iXBRL 10-K 1661075
2 EX-4.2 itci-20231231xex42.htm EX-4.2 15370
3 EX-10.35 itci-20231231xex1035.htm EX-10.35 32705
4 EX-23.1 itci-20231231xex231.htm EX-23.1 4421
5 EX-31.1 itci-20231231xex311.htm EX-31.1 7740
6 EX-31.2 itci-20231231xex312.htm EX-31.2 7787
7 EX-32.1 itci-20231231xex321.htm EX-32.1 4613
13 itci-20231231_g1.jpg GRAPHIC 149255
  Complete submission text file 0001628280-24-006156.txt   7483141

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itci-20231231.xsd EX-101.SCH 41433
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT itci-20231231_cal.xml EX-101.CAL 79096
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT itci-20231231_def.xml EX-101.DEF 177932
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itci-20231231_lab.xml EX-101.LAB 577076
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itci-20231231_pre.xml EX-101.PRE 375212
79 EXTRACTED XBRL INSTANCE DOCUMENT itci-20231231_htm.xml XML 976271
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36274 | Film No.: 24662332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)